[LGND] YoY Quarter Result on 30-Sep-2011 [#Q3]

Stock
[LGND] Ligand Pharmaceuticals Incorporated
Announcement Date
08-Nov-2011
Financial Year
2011
Quarter
30-Sep-2011 [#Q3]
Profit Trend
QoQ- -327.35%
YoY- 67.02%
Quarter Report
LGND's Result
LGND's Financial Summary
View:
Show?
Quarter Result
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Revenue 14,973 13,005 6,375 5,741 7,802 7,901 5,248 19.08%
PBT 901 2,025 -52 -3,884 -11,436 1,055 -6,134 -
Tax 124 60 142 22 419 -748 2,990 -41.15%
NP 1,280 1,965 -194 -3,906 -11,843 1,803 -18,125 -
Tax Rate -13.76% -2.96% - - - 70.90% - -
Total Cost 13,693 11,040 6,569 9,647 19,645 6,098 23,373 -8.52%
Ratio Analysis
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
NP Margin 8.55 15.11 -3.04 -68.04 -151.79 22.82 -345.37 -
Per Share
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
EPS 0.06 0.10 -0.01 -0.20 -0.60 0.12 -1.14 -
EPS Diluted 0.06 0.09 -0.01 -0.20 -0.60 0.12 -1.14 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.